Strategic Analysis of U.S. MicroRNA Services Markets

This Frost & Sullivan research service titled Strategic Analysis of the U.S. MicroRNA Services Markets provides a detailed analysis of the challenges facing micro ribonucleic acid (microRNA) services providers along with recommendations for overcoming growing competition and other limitations. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: microRNA expression profiling and phenotypic screening.

Market Overview

Researchers’ Need for Swift and Precise Results to Publish Boosts the United States MicroRNA Services Market

Researchers have been eager to publish in the emerging microRNA field and are on the lookout for service providers offering microRNA expression profiling that is accurate, reproducible, have high-throughput results, and rapid turnaround times. “The rapid discoveries linking microRNAs to various diseases have boosted the microRNA market as well as the market for services and tools,” says the analyst of this research. “When this field progresses beyond the discovery stage, it will be critical for services providers to evolve and deliver distinctive microRNA services.”

Services for microRNA expression profiling by microarray were the first microRNA services to enter the market and continue to be the most widely available. Ever since, providers have responded to the needs of microRNA researchers and have added microRNA quantitative real-time polymerase chain reaction (qRT-PCR) assays, microRNA phenotypic screening, and microRNA sequencing services to the market.

The rapid growth of the microRNA services market has resulted in several new competitors entering the market over the last few years. Therefore, service providers should differentiate themselves by offering unique platforms and cutting-edge services. “In a mere three years, the microRNA services market has attracted over fifteen competitors,” notes the analyst. “As companies continue to jockey for brand recognition and market share, it has become critical for providers to establish unique positions within the microRNA services market to stand out from the crowd.” Several companies have launched one-of-a-kind services, such as microRNA phenotypic screening and microRNA sequencing, while others have opted to utilize microarrays developed in-house that are commercially unavailable. Providers should innovate and keep abreast of research trends to stay competitive.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

• MicroRNA expression profiling
• MicroRNA phenotypic screening
• Technologies

• Microarrays
• qRT-PCR
• Inhibitors and mimics
• Sequencing